The present invention relates to new compounds of formula (I), wherein Q is a partially saturated ring or Nl-oxides, salts, solvates or solvated salts thereof, processes for their preparation and new intermediates used in the preparation thereof and to the use of said compounds as metabotropic glutamate receptors ligands in therapy.
本发明涉及公式(I)的新化合物,其中Q是部分饱和环或N-氧化物,其盐、溶剂合物或溶剂化合物盐,以及其制备工艺和用于制备中的新中间体,以及将所述化合物用作治疗中的代谢型谷
氨酸受体
配体。